The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence...
Date First Received: April 5, 2002
Last Updated: July 28, 2008
Verified by: National Institute on Drug Abuse (NIDA), July 2008
Clinical Trial Phase: Phase 3 | Start Date: April 2001
Overall Status: Completed
Estimated Enrollment: 390
Brief Summary
Official Title: “Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics”
Condition Keyword(s):
Intervention(s):
The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.
Study Type: Interventional
Study Design: Treatment, Randomized
Study Primary Completion Date: February 2003
Detailed Clinical Trial Description
The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics. The study will determine if motivational incentives along with standard care therapy is more effective than standard therapy alone for the treatment of patients using cocaine or methamphetamine and entering a substance abuse treatment program.
Intervention(s) in this Clinical Trial
- Behavioral: Behavior Therapy
Outcome Measures for this Clinical Trial
Primary Measures
- ASI
- Opioid and cocaine use
- AIDS risk behavior
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- 1. Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry
- 2. Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment
Exclusion Criteria:
- 1. Unable to give informed consent (fails simple consent quiz)
- 2. Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: National Institute on Drug Abuse (NIDA)
Overall Clinical Trial Officials and Contacts
Maxine Stitzer, Ph.D. Principal Investigator Johns Hopkins University
Additional Information
Information obtained from ClinicalTrials.gov on October 06, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00033020
Study ID Number: NIDA-CTN-0007-1
ClinicalTrials.gov Identifier: NCT00033020
Health Authority: United States: Federal Government
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
